Search research articles
Contact Us
Filters
Showing results (21-30 of 24) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 24 results.
Journal of the National Cancer Institute
|
February 7, 1990
Low- versus high-dose interferon alfa-2a in relapsed indolent non-Hodgkin's lymphoma
L A VanderMolen, R G Steis, P L Duffey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 18, 1997
Alternating MOPP and ABVD chemotherapy plus mantle-field radiation therapy in patients with massive mediastinal Hodgkin's disease
D L Longo, E Glatstein, P L Duffey, et al.
Cancer Journal (Sudbury, Mass.)
|
July 6, 2000
Combination chemotherapy followed by an immunotoxin (anti-B4-blocked ricin) in patients with indolent lymphoma: results of a phase II study
D L Longo, P L Duffey, J G Gribben, et al.
Nature Medicine
|
September 30, 1999
Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma
M Bendandi, C D Gocke, C B Kobrin, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 24) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 24 results.
Journal of the National Cancer Institute
|
February 7, 1990
Low- versus high-dose interferon alfa-2a in relapsed indolent non-Hodgkin's lymphoma
L A VanderMolen, R G Steis, P L Duffey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 18, 1997
Alternating MOPP and ABVD chemotherapy plus mantle-field radiation therapy in patients with massive mediastinal Hodgkin's disease
D L Longo, E Glatstein, P L Duffey, et al.
Cancer Journal (Sudbury, Mass.)
|
July 6, 2000
Combination chemotherapy followed by an immunotoxin (anti-B4-blocked ricin) in patients with indolent lymphoma: results of a phase II study
D L Longo, P L Duffey, J G Gribben, et al.
Nature Medicine
|
September 30, 1999
Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma
M Bendandi, C D Gocke, C B Kobrin, et al.
Page
of 3